Thalidomide-5-Br
Thalidomide-5-Br (compound 4) is a compound with a bromodomain. Thalidomide-5-Br can be used in the research of inflammation, tumor and neurology[1].
Product Specifications
CAS Number
[26166-92-7]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/thalidomide-5-br.html
Purity
99.12
Smiles
O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=CC(Br)=C3)=O
Molecular Formula
C13H9BrN2O4
Molecular Weight
337.13
Precautions
H302, H315, H319, H335
References & Citations
[1]Yeung, et al. "Novel thalidomide analogues with potent NFκB and TNF expression inhibition." MedChemComm 2.11 (2011) : 1073-1078.
Shipping Conditions
Room Temperature
Storage Conditions
Store at room temperature 3 years
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1120654-01 0.02 mg (E-Coli)
Recombinant Janthinobacterium sp. Ribonuclease H (rnhA)
Ask
View Details 
MBS1120654-02 0.1 mg (E-Coli)
Recombinant Janthinobacterium sp. Ribonuclease H (rnhA)
Ask
View Details MBS1120654-03 0.02 mg (Yeast)
Recombinant Janthinobacterium sp. Ribonuclease H (rnhA)
Ask
View Details 
MBS1120654-04 0.1 mg (Yeast)
Recombinant Janthinobacterium sp. Ribonuclease H (rnhA)
Ask
View Details 
MBS1120654-05 0.02 mg (Baculovirus)
Recombinant Janthinobacterium sp. Ribonuclease H (rnhA)
Ask
View Details MBS1120654-06 0.02 mg (Mammalian-Cell)
Recombinant Janthinobacterium sp. Ribonuclease H (rnhA)
Ask
View Details